A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Once home, I was convinced I’d never sleep again for fear of more episodes of apnea. We purchased a specialized baby monitor ...

The technology could be adapted for other common respiratory viruses such as seasonal influenza, avian flu and respiratory syncytial virus (RSV ... infected did not pass the virus on to others, ...

Norovirus has no treatment and is highly contagious. It can linger on objects and surfaces for days or even weeks, as it’s resistant to most disinfectants and hand sanitizers, according to the ...

COVID-19 has been more prevalent and has caused more deaths than flu or respiratory syncytial virus (RSV ... gender disparities … Study: REM cycle delays could indicate Alzheimer’s ...

Opens in a new tab or window The 24-hour news cycle is just as important to ... Topics include a new warning on two respiratory syncytial virus (RSV) vaccines, the "Shkreli Awards," and a link ...